IPG-ONDANSETRON 8 MG — DIN 02304600
ONDANSETRON (ONDANSETRON HYDROCHLORIDE) : 8 MG · MARCAN PHARMACEUTICALS INC · TABLET · wholesale supply in Canada
Health Canada status: APPROVED
What is IPG-ONDANSETRON?
IPG-ONDANSETRON 8 MG contains ONDANSETRON (ONDANSETRON HYDROCHLORIDE) : 8 MG. It is listed in the Health Canada Drug Product Database under DIN 02304600, held by MARCAN PHARMACEUTICALS INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as approved, status dated 29-Feb-2016. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A). This DIN is not currently being marketed in Canada, so it is sourced to order where a compliant route exists rather than held in stock.
How much does Ondansetron cost around the world?
Ondansetron is listed on 17 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Australia | ex-manufacturer | 20 | 96 | AUD███.██ |
| Sweden | AIP (pharmacy purchase price) | 13 | 60 | SEK███.██ |
| United States | acquisition | 6 | 60 | USD███.██ |
| Saudi Arabia | public | 34 | 55 | SAR███.██ |
| South Africa | single exit price | 43 | 49 | ZAR███.██ |
| Bahrain | retail (max) | 15 | 33 | BHD███.██ |
| Greece | producer price (ex-factory) | 29 | 29 | EUR███.██ |
| Morocco | PPV (public price) | 11 | 29 | MAD███.██ |
| Czechia | max producer price (ex-factory) | 8 | 12 | CZK███.██ |
| Austria | KVP (Kassenverkaufspreis) | 11 | 11 | EUR███.██ |
| United Kingdom | hospital | 10 | 10 | GBP███.██ |
| United Arab Emirates | public | 6 | 8 | AED███.██ |
| Spain | PVP con IVA (public price) | 8 | 8 | EUR███.██ |
| Romania | max producer price | 7 | 8 | RON███.██ |
| Hungary | producer price (ex-factory) | 5 | 7 | HUF███.██ |
| Norway | max AUP (pharmacy retail) | 3 | 4 | NOK███.██ |
| Luxembourg | reimbursement | 1 | 1 | EUR███.██ |
480 pack listings across 230 brand entries and 15 price bases, refreshed 08 Sep 2026. Ranges span every Ondansetron pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Ondansetron in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
43 holders have a Canadian DIN containing Ondansetron, across 135 DINs, of which 59 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| JAMP PHARMA CORPORATION | 13 | 7 | JAMP ONDANSETRON, JAMP ONDANSETRON ODF, JAMP ONDANSETRON ODT, JAMP ONDANSETRON TABLETS, JAMP-ONDANSETRON, +1 more | Sourceable in Canada |
| SANDOZ CANADA INCORPORATED | 9 | 7 | ONDANSETRON HYDROCHLORIDE DIHYDRATE INJECTION, ONDANSETRON INJECTION USP -(PRESERVATIVE FREE), ONDANSETRON INJECTION USP -(WITH PRESERVATIVE), ONDANSETRON ODT, SANDOZ ONDANSETRON, +1 more | Sourceable in Canada |
| MARCAN PHARMACEUTICALS INC | 8 | 5 | IPG-ONDANSETRON, MAR-ONDANSETRON, MAR-ONDANSETRON ODT, ONDANSETRON INJECTION USP | Sourceable in Canada |
| AURO PHARMA INC | 6 | 5 | AURO-ONDANSETRON INJECTION, AURO-ONDANSETRON ODT, ONDANSETRON INJECTION BP | Sourceable in Canada |
| MINT PHARMACEUTICALS INC | 5 | 5 | MINT-ONDANSETRON, MINT-ONDANSETRON ODT, MINT-ONDANSETRON SOLUTION | Sourceable in Canada |
| ACCEL PHARMA INC | 4 | 4 | ACCEL-ONDANSETRON, ACCEL-ONDANSETRON ODT | Sourceable in Canada |
| PHARMASCIENCE INC | 4 | 4 | PMS-ONDANSETRON, PMS-ONDANSETRON ODT | Sourceable in Canada |
| SANIS HEALTH INC | 4 | 4 | ONDANSETRON, ONDANSETRON ODT | Sourceable in Canada |
| APOTEX INC | 3 | 3 | APO-ONDANSETRON | Sourceable in Canada |
| TEVA CANADA LIMITED | 6 | 2 | ONDANSETRON INJECTION, TEVA-ONDANSETRON | Sourceable in Canada |
| EUGIA PHARMA INC. | 4 | 2 | EUGIA-ONDANSETRON INJECTION, ONDANSETRON INJECTION BP | Sourceable in Canada |
| MYLAN PHARMACEUTICALS ULC | 4 | 2 | MYLAN-ONDANSETRON, ONDANSETRON INJECTION, USP | Sourceable in Canada |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 8 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Ondansetron |
|---|---|
| ATC code | A04AA01 |
| AHFS class | 84:80.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02304600 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2304600 |
| Brand name | IPG-ONDANSETRON |
| Generic / active ingredient | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) : 8 MG |
| Market authorization holder | MARCAN PHARMACEUTICALS INC |
| Health Canada schedule | Prescription |
| ATC code | A04AA01 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A04AA |
| Current status | APPROVED |
| Status date | 29-Feb-2016 |
| Original market date | 2008-04-05 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
Is Ondansetron in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by SANDOZ CANADA INCORPORATED, last seen 09 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
59 of 135 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACCEL-ONDANSETRON | 4 MG | TABLET | ACCEL PHARMA INC | MARKETED | 02478927 |
| ACCEL-ONDANSETRON | 8 MG | TABLET | ACCEL PHARMA INC | MARKETED | 02478935 |
| ACCEL-ONDANSETRON ODT | 4 MG | TABLET (ORALLY DISINTEGRATING) | ACCEL PHARMA INC | MARKETED | 02535319 |
| ACCEL-ONDANSETRON ODT | 8 MG | TABLET (ORALLY DISINTEGRATING) | ACCEL PHARMA INC | MARKETED | 02535327 |
| APO-ONDANSETRON | 8 MG | TABLET | APOTEX INC | MARKETED | 02288192 |
| APO-ONDANSETRON | 4 MG / 5 ML | SOLUTION | APOTEX INC | MARKETED | 02291967 |
| APO-ONDANSETRON | 4 MG | TABLET | APOTEX INC | MARKETED | 02288184 |
| AURO-ONDANSETRON INJECTION | 2 MG | SOLUTION | AURO PHARMA INC | MARKETED | 02491524 |
| AURO-ONDANSETRON INJECTION | 2 MG | SOLUTION | AURO PHARMA INC | MARKETED | 02491532 |
| AURO-ONDANSETRON ODT | 4 MG | TABLET (ORALLY DISINTEGRATING) | AURO PHARMA INC | MARKETED | 02511282 |
2 · Same class — other molecules in ATC A04AA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Ondansetron | ACCEL-ONDANSETRON · ACCEL-ONDANSETRON ODT · AG-ONDANSETRON · APO-ONDANSETRON · +53 more | 135 | 59 | Yes |
| Granisetron | APO-GRANISETRON · GRANISETRON HYDROCHLORIDE INJECTION · GRANISETRON HYDROCHLORIDE INJECTION SDZ · GRANISETRON HYDROCHLORIDE INJECTION USP · +4 more | 10 | 3 | Yes |
| Palonosetron | ALOXI | 2 | 1 | Yes |
| Palonosetron, Combinations | AKYNZEO | 1 | 1 | Yes |
| Dolasetron | ANZEMET · ANZEMET INJECTION 20 MG/ML | 3 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC A04A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| A04AD | Aprepitant · Dronabinol · Nabilone · Other Antiemetics · Scopolamine | 29 | 14 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is IPG-ONDANSETRON called?
The same molecule, Ondansetron, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Zofran | Latin | Australia, Bahrain, Czechia, Morocco, Norway, Saudi Arabia |
| Ondansetron Bluefish | Latin | Norway, Sweden |
| Dantron | Latin | Morocco, South Africa |
| Ondansetron Abacus Medicine | Latin | Sweden |
| Ondansetron Ebb | Latin | Sweden |
| APX-Ondansetron | Latin | Australia |
| APX-Ondansetron ODT | Latin | Australia |
| CHEMOSET | Latin | Morocco |
| Ondansetron EQL Pharma | Latin | Sweden |
| Ondansetron ODT Viatris | Latin | Australia |
| Ondansetron ODT-DRLA | Latin | Australia |
| ONDANSETRON ODT-WGR | Latin | Australia |
| Ondansetron SZ | Latin | Australia |
| Ondansetron SZ ODT | Latin | Australia |
| Ondansetron Tablets Viatris | Latin | Australia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
This product is approved by Health Canada but not yet marketed in Canada, so there is no Canadian supply to draw on today. Nexara can tell you whether it has been launched, and can look at supply from other markets where a Canadian pack is not required or where importation is permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.